Chymase inhibitor improves dermatitis in NC/Nga mice

International Archives of Allergy and Immunology

Volumn 128, Issue 3, 2002, Pages 229-234

  Watanabe, Naohiro ^a   Tomimori, Yoshiaki ^b   Saito, Kayo ^b   Miura, Kenju ^b   Wada, Adumi ^c   Tsudzuki, Masaoki ^d   Fukuda, Yoshiaki ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SUNTORY LTD   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Chymase; Eosinophils; Mast cells; NC Nga mice

Indexed keywords

CHYMASE INHIBITOR; ENZYME INHIBITOR; SUN C 8257; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DRUG EFFECT; ENZYME INHIBITION; EOSINOPHIL; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SKIN DISEASE;

ANIMALS; CHYMASES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EOSINOPHILS; MAST CELLS; MICE; MICE, INBRED BALB C; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036066693     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064256     Document Type: Article

References (28)

1. Atopic dermatitis
2. The structure of normal skin and the morphology of atopic eczema
3. Chymase: Its pathophysiological roles and inhibitors
4. Experimental itch in human skin elicited by rat mast cell chymase
5. The induction of a prolonged increase in microvascular permeability by human mast cell chymase
6. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo
7. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase
8. Chymase cleavage of stem cell factor yields a bioactive, soluble product
9. IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody
10. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo
11. Angiotensin II-forming activity in a reconstructed ancestral chymase
12. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase
13. Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice
14. Angiotensin II generation by mast cell alpha- and beta-chymases
15. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice
16. Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase
17. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain
18. Cloning and structural analysis of MMCP-1, MMCP-4 and MMCP-5, three mouse mast cell-specific serine proteases
19. Purification of soluble murine interleukin 5 (IL-5) receptor alpha expressed in Chinese hamster ovary cells and its action as an IL-5 antagonist
20. Thymopentin therapy reduces the clinical severity of atopic dermatitis
21. Protective immunity and eosinophilia in IgE-deficient SJA/9 mice infected with Nippostrongylus brasiliensis and Trichinella spiralis
22. The involvement of CD80 and CD86 costimulatory molecules in the induction of eosinophilia in mice infected with Nippostrongylus brasiliensis
23. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis
24. Effect of scratching behavior on the development of dermatitis in NC/Nga mice
25. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis
26. Assessment of eosinophil and neutrophil participation in atopic dermatitis: Comparison with the IgE-mediated late-phase reaction
27. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo
28. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor